Alembic Pharmaceuticals
APLLTDNSE

Alembic Pharmaceuticals

₹765.7510.75 (1.42%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
755.00
Today’s high
770.95
52 week low
635.80
52 week high
1,107.90
Open price
759.95
Previous close
755.00
Live volume
3,38,157
Lower circuit
604.00
Upper circuit
906.00

Fundamentals

Market Cap
₹14,831Cr
ROE
11.93%
P/E Ratio(TTM)
23.70
EPS(TTM)
31.84
P/B Ratio
2.79
Dividend Yield
1.46%
Industry P/E
33.38
Book Value
270.62
Debt to Equity
0.28
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹1,892
-1.32%
Profit (Cr)
₹132
-28.17%
05001k1.5k2k
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+11%
3Y CAGR+8%
Profit growthValue
1Y (TTM)-4%
3Y CAGR+4%

About

Established in 1907, Alembic Pharmaceuticals is a prominent research-driven, integrated pharmaceutical company that specializes in producing generic medicines and active pharmaceutical ingredients (APIs) for global markets. The company's core mission is to improve healthcare worldwide by focusing on innovation, maintaining a strong commitment to quality, and building trust with patients and healthcare providers. It leverages its expertise in chemistry and formulation to create high-quality, affordable medicines, making healthcare more accessible to a wider population across the globe. Its operations are strategically structured into three key areas: selling branded medicines in India, exporting generic drugs internationally, and manufacturing Active Pharmaceutical Ingredients. Headquartered in Vadodara, Gujarat, the company operates several advanced, FDA-approved manufacturing facilities in Gujarat and Sikkim which form the backbone of its global supply capabilities. With 756 cumulative product filings across the world, Alembic has established a strong and expanding presence in both regulated and emerging international pharma markets.;
CEO/MD
Chirayu Amin
Founded in
1907
NSE symbol
APLLTD

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
69.74%
Retail And Others
9.83%
Mutual Funds
8.18%
Other Domestic Institutions
8.00%
Foreign Institutions
4.25%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Natco PharmaNATCOPHARM
₹1,114.60
+18.85 (1.72%)
L
    H
    19,627.7612.622.27
    ₹1,353.60
    +30.70 (2.32%)
    L
      H
      18,325.7638.935.21
      ₹703.40
      +3.70 (0.53%)
      L
        H
        17,327.2029.123.41
        ₹931.40
        +4.80 (0.52%)
        L
          H
          14,763.1334.382.24
          Livesquawk
          Alembic Pharma records NSE block trade worth Rs. 15.5 Cr for 201,791 shares. Shares traded at Rs. 769.05 each during the block trade.
          Livesquawk
          Alembic Pharma gets US FDA approval for Paroxetine ER 12.5 mg tablets. This approval brings Alembic's total US ANDA approvals to 235.
          2026
          15
          May
          Annual Result
          Upcoming
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          4
          Nov
          Quarterly Result
          Release date
          5
          Aug
          Quarterly Result
          Release date

          29
          Jul
          Dividend
          Ex date
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date29 Jul ‘25
          Record Date29 Jul ‘25
          Announcement date6 May ‘25

          6
          May
          Dividend
          Announced
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date29 Jul ‘25
          Record Date29 Jul ‘25
          Announcement date6 May ‘25
          2024

          15
          Jul
          Dividend
          Ex date
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date15 Jul ‘24
          Record Date15 Jul ‘24
          Announcement date9 May ‘24

          9
          May
          Dividend
          Announced
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date15 Jul ‘24
          Record Date15 Jul ‘24
          Announcement date9 May ‘24
          Events calendar
          View upcoming events in other stocks